መነሻ › የፕሮስቴት ካንሰር › Utah › Salt Lake City
በSalt Lake City፣ UT ለየፕሮስቴት ካንሰር የሚደረጉ ክሊኒካዊ ጥናቶች
ለየፕሮስቴት ካንሰር የሚደረጉ 15 ጥናቶች በSalt Lake City እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።
Official study text (English)
ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →
Study of AR Suppression With Carotuximab in Metastatic, Castration-Resistant Prostate Canc
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Huntsman Cancer Institute and Hospital, Salt Lake City
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- University of Utah - Huntsman Cancer Institute, Salt Lake City
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
ተሳታዮችን በመፈለግ ላይደረጃ 3
- LDS Hospital, Salt Lake City
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Huntsman Cancer Institute, Salt Lake City
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 3
- University of Utah Sugarhouse Health Center, Salt Lake City
- Huntsman Cancer Institute/University of Utah, Salt Lake City
- LDS Hospital, Salt Lake City
- እና 1 ተጨማሪ
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Research Site, Salt Lake City
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Huntsman Cancer Institute/University of Utah, Salt Lake City
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Huntsman Cancer Institute, University of Utah, Salt Lake City
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Huntsman Cancer Institute/University of Utah, Salt Lake City
Creatine Supplementation and Resistance Training to Preserve Muscle Mass and Attenuate Cancer Progression
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Huntsman Cancer Institute, Salt Lake City
Multimodal Telerehabilitation of Rural Patients With Advanced Prostate Cancer
ተሳታዮችን በመፈለግ ላይ
- Huntsman Cancer Institute at University of Utah, Salt Lake City
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- START Center for Cancer Care - Mountain Region, Salt Lake City
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Massive Bio SYNERGY-AI site, Salt Lake City
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 3
- University of Utah Sugarhouse Health Center, Salt Lake City
- Huntsman Cancer Institute/University of Utah, Salt Lake City
- George E Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
Impact of Multimodal Telerehabilitation in Rural Patients With Metastatic Prostate Cancer
ተሳታዮችን በመፈለግ ላይ
- University of Utah Huntsman Cancer Institute, Salt Lake City
በሌሎች ከተሞች ለየፕሮስቴት ካንሰር የሚደረጉ ጥናቶች
- New York City, NY103 ጥናቶች
- Houston, TX76 ጥናቶች
- Los Angeles, CA61 ጥናቶች
- Boston, MA59 ጥናቶች
- St. Louis, MO46 ጥናቶች
- Chicago, IL45 ጥናቶች
- San Francisco, CA45 ጥናቶች
- Philadelphia, PA44 ጥናቶች
- Baltimore, MD43 ጥናቶች
- Nashville, TN43 ጥናቶች
- Seattle, WA42 ጥናቶች
- Washington, DC38 ጥናቶች
በSalt Lake City ውስጥ ያሉ ሌሎች ጥናቶች
- ኖን-ስማል ሴል የሳንባ ካንሰር31 ጥናቶች
- ካንሰር (ሁሉም ዓይነቶች)27 ጥናቶች
- የጡንቻ ካንሰር27 ጥናቶች
- የኮሎሬክታል ካንሰር22 ጥናቶች
- የሳንባ ካንሰር21 ጥናቶች
- ሜላኖማ21 ጥናቶች
- Multiple Myeloma21 ጥናቶች
- Metastatic Cancer20 ጥናቶች
- የእንቁላል ካንሰር19 ጥናቶች
- ከባድ ሰውነት18 ጥናቶች
- አኩት ማይሎይድ ሊውኬሚያ17 ጥናቶች
- የልብ ድካም17 ጥናቶች
ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።